NKE vs TMO: Which Is the Better Buy?
Side-by-side comparison of NIKE, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
NIKE, Inc. · Consumer Cyclical
$42.62
+45.5% upside to fair value
Med Conviction
Grade B+
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
NKE has more upside to fair value
(+45.5%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NKE |
TMO |
| Current Price |
$42.62 |
$462.60 |
| Fair Value Estimate |
$62.00 |
$509.20 |
| Upside to Fair Value |
+45.5%
|
+10.1%
|
| Market Cap |
$63.0B |
$171.9B |
| Forward P/E |
27.9x
|
25.1x
|
| EV / EBITDA |
20.7x
|
19.0x
|
| Price / Sales |
1.4x
|
3.8x
|
| Price / FCF |
19.4x
|
25.5x
|
| Revenue Growth YoY |
-9.8%
|
+6.2%
|
| Gross Margin |
42.7%
|
39.4%
|
| Operating Margin |
8.0%
|
17.8%
|
| Return on Equity |
24.4%
|
13.3%
|
| Dividend Yield |
3.8% |
0% |
| FCF Yield |
5.2%
|
3.92%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
NKE |
TMO |
| Zone Low |
$44.00 |
$381.90 |
| Zone High |
$50.00 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|